Meningitis/Encephalitis Flashcards
1
Q
Common organisms in meningitis
A
Adults <60
- Streptococcus pneumoniae
- Neisseria meningitides
- Less common: H influenza, L. monocytogenes, S. agalactiae
Adults <>60
- Streptococcus pneumoniae
- Listeria monocytogenes
- Less common: N. meningitides, S. agalactiae, H influenza
2
Q
Clues to pathogen in meningitis:
A
- Pneumococcal → predisposing coniditions (otitis media, sinusitis, mastroiditis, CSF leak, cochlear implants, asplenia, HIV/AIDs, immunosuppressed)
- Meningococcal → young adults without comorbidities (abscence of rash not useful in excluding diagnosis)
- Listeria → consider if immunosuppressed, diabetic, alcoholic, cirrhosis, ESRF, malignancy, HIV/AIDs, organ transplantation
3
Q
CSF interpretation in bacterial meningitis:
A
- Gram stain positive in 60%
- Protein >1g/L
- CSF-blood glucose ratio ≤0.5
- WCC count >1000 (>50% PMNs). Caveats:
- 10% bacterial meningitis bases WCC<100
- Listeria meningitis may be lymphocytic
- Viral meningitis may be neutrophilic in first 48 hours
- S. pneumoniae antigen → specificity ≥95%, sensitivity ≥85% (better than gram stain and culture)
- PCR panel:
- N. meningitides, S. pneumoniae, L.monocytogenes, enterovirus, HSV and VZV
- Pre-antibiotics >95% sensitivity
- N. meningitides, S. pneumoniae, L.monocytogenes, enterovirus, HSV and VZV
4
Q
Role of dexamethasone in bacterial meningitis:
A
- Benefit in pneumococcal meningitis
- Reduces mortality and hearing loss and other neurological sequelae
- Reduces neuronal damage by → reducing CNS inflammation, oedema, ICP, and reducing inflammatory response from antibiotic-mediated bacteriolysis → should be given before or with first dose of antibiotics
- 10mg IV Q6H for 4/7
- Not harmful in menigococcal meningitis - but can be stopped when confirmed
5
Q
Empiric treatment of bacterial meningitis
A
- Ceftriaxone will cover all strains of N.mengitides and most strains of strep pneumoniae
- Likely that ceftriaxone still safe in penicillin allergy but moxifloxacin is an alternative
- If risk of ceftriaxone resistant strep. pneumoniae → add vancomycin
- 3% in Auckland in 2018
- Penicillin or co-trim if at risk of listeria
6
Q
Infection control precautions for N.meningitides and post-exposure propylaxis
A
- Droplet precautions until 24 hours of effective antibiotics administered
- PEP for household contacts and HCWs who have performed airway management without a mask
- Rifampicin 600mg PO BD for 4 doses/Ciprofloxacilin 500mg once only
- Ceftriaxone 250mg IM preferred in pregnancy
7
Q
Notes on Japenese Encephalitis Virus → epidemiology, virology, natural course and diagnostic testing and treatment
A
- Single stranded RNA mosquito borne flavivirus - Australia outbreak 2022
- Most cases are asymptomatic or cause a non-specific febrile illness
- <1% neuroinvasive disease
- Mortality 20-30% in hospitalised patients, long term sequelae 30-50%. Most important cause of viral encephalitis in Asia and the Western Pacific.
- Disease course post incubation (5-15 days)
- Initial symptoms non-specific → mental state changes, focal neurological deficits (paresis, hemoplegia, tetraplegia or CN palsies) and or movement disorders
- Poor prognostic factors → multiple seizures and raised ICP, flexor and extensor posturing, abnormal pupillary and oculocephalic reflexes
- Diagnostic testing → serological testing of IgM in the CSF or serum, viral isolation confirmatory but rare. MRI → changes in the thalamus (most common), basal ganglia, midbrain, pons and medulla
- Treatment → supportive
- Vaccine → those who work with pigs, mosquitos, research staff who may be exposed